Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. MASIMO CORPORATION
WARNING LETTER
•MASIMO CORPORATION•October 3, 2013

MASIMO CORPORATION – FDA Warning Letter, Oct 3, 2013

Record Details

An FDA inspection of Masimo Corporation in Irvine, CA, from August to October 2013, found their Rainbow SET Pronto-7 Pulse CO-Oximeter and Rad-8 Signal Extraction Pulse Oximeter devices adulterated. The firm's manufacturing methods, facilities, or controls did not conform to the Quality System regulation (21 CFR Part 820). Key violations included the failure to adequately review, evaluate, and investigate device complaints (21 CFR 820.198(c)), and complaint investigation records lacked required details (21 CFR 820.198(e)). Furthermore, Masimo failed to establish and maintain adequate corrective and preventive action (CAPA) procedures, specifically in identifying all potentially affected nonconforming products (21 CFR 820.100(a)(3)) and thoroughly investigating the cause of nonconformities (21 CFR 820.100(a)(2)). The firm's Medical Device Reporting (MDR) procedure also contained an inadequate definition of "caused or contributed" to a serious injury or death, not aligning with 21 CFR 803.3. The company's responses to the FDA 483 observations were deemed inadequate. Masimo must promptly correct these violations and provide a written response within fifteen working days, detailing corrective actions, prevention plans, and a timetable. Failure to comply may result in regulatory actions like seizure, injunction, civil money penalties, and impact on federal contracts. A regulatory meeting was requested.

Company
MASIMO CORPORATION
Inspection date
October 3, 2013
Product type
Devices
Office
Los Angeles District Office
People
  • Alonza E. Cruse (Director)
  • Harlan Loui
View Company Profile

ID · 20df8095-75f3-48e2-823f-e4e039f1585b

Violation Codes9
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 820.198(c)21 CFR 820.198(e)21 CFR 820.100(a)(3)21 CFR 820.100(a)(2)21 CFR 80321 CFR 82021 CFR 803.3

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MASIMO CORPORATION
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.